Relevium Expands CleanCare Offering as International Organizations Call for Increased Institutional and Government Stockpile of Supplies

- June 19th, 2020

Relevium Technologies Inc. is pleased to announce it has expanded and continues to expand its CleanCare™ product line as it prepares to address increased government and institutional demand for disinfection supplies in preparation for a potential second wave of COVID-19.

Relevium Technologies Inc. (TSXV: RLV, OTC: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce it has expanded and continues to expand its CleanCare™ product line as it prepares to address increased government and institutional demand for disinfection supplies in preparation for a potential second wave of COVID-19.

On June 18, 2020 CBC News reported that NATO nations have agreed to stockpile medical equipment and essential supplies to prepare for an anticipated second wave of the Covid-19. Defense Ministers from NATO have asked member nations to contribute to an emergency fund to buy even more supplies as the alliance braces for a second wave of the pandemic. Municipal, Regional and Federal governments and institutions are also following suit, and the demand for North American made and compliant products increase daily.

Relevium Technologies continues to innovate and bring new products to market to address market demand for critical health and wellness products including surface disinfectants in the form of liquid sprays and wipes, targeting B2B institutional and government customers. The company’s new product pipeline now includes Air purification systems, seven (7) new formats of gel and liquid sanitizers, surface disinfectants, wipes, and a new alcohol-free product line.

Aurelio Useche stated: “The Company is preparing a B2B and B2C strategy to bring CleanCare™ Air Purifiers, alcohol free formulas and differentiating technology to market via national retailers, institutional wholesalers and direct-to-consumers through specialized e-commerce partners”

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

About Relevium Technologies

Relevium is a publicly traded Company that operates in the health and wellness industry, including legal cannabis, with a primary focus on online distribution. The principal business of the Company is the identification, evaluation, acquisition and operation of brands and businesses in the health and wellness markets and medical cannabis. The Company pursues its business strategy through an acquisition and partnership model in a holistic approach to encompass a wide range of health and wellness consumer products. Relevium operates through two wholly owned subsidiaries:

BGX E-Health LLC (BGX), based in Orlando, Florida, markets dietary supplements, nutraceuticals, sports nutrition, and cosmeceuticals primarily through its Bioganix® brand portfolio in the US and Europe.

Relevium’s premium brands are sold at some of the world’s largest retailers including Walmart.com and Amazon.com.

Biocannabix Health Corporation (BCX), based in Montreal, Quebec, is a biopharma nutraceutical Company focused on delivering pediatric endo-medicinal nutraceuticals for cannabinoid therapy.

Cautionary Note Regarding Forward-Looking Statements
This release includes certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian and United States securities laws. All statements in this news release, other than statements of historical facts, including statements regarding future estimates, plans, objectives, assumptions, or expectations of future performance, are forward-looking statements and contain forward-looking information. Generally, forward- looking statements and information can be identified by the use of forward-looking terminology such as “intends” or “anticipates”, or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “should”, or “would” occur.  Forward-looking statements are based on certain material assumptions and analysis made by the Company and the opinions and estimates of management as of the date of this press release. These forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking statements or forward-looking information.

Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward- looking statements and forward-looking information. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not undertake to update any forward-looking statement, forward-looking information or financial outlook that are incorporated by reference herein, except in accordance with applicable securities laws. We seek to rely on the applicable safe harbor.

On Behalf of the Board of Directors

RELEVIUM TECHNOLOGIES INC.

Aurelio Useche
President and CEO

For more information about this press release:

Tel: +1.888.528.8687

RELEVIUM TECHNOLOGIES INC
Email: investors@releviumcorp.com
Website: www.releviumtechnologies.com
Like us on Facebook
Follow us on Twitter
Follow us on LinkedIn

Primary Logo

GlobeNewswire
June 19, 2020 – 9:19 AM PDT
News by QuoteMedia

Get the latest Cannabis Investing stock information

Tags

Tags:

Leave a Reply